Japan is using big teams of public health nurses to perform “cluster busting” contact tracing. A thread summarizing their approach, as described in this translated (almost official) guidance document now on the web. 1/11 https://drive.google.com/file/d/1RxLGyRhdKcW-g_laLb7SQxFanW_kJcRP/view https://www.bloomberg.com/news/articles/2020-06-23/the-low-tech-way-that-japan-managed-to-tackle-the-virus-quickly
Japan didn’t need to hire large teams of contact tracers. They were already in place. Nurses at their public health centers routinely contact community residents to provide health education and services (check on newborns, advise the elderly). https://www.bloomberg.com/news/articles/2020-06-23/the-low-tech-way-that-japan-managed-to-tackle-the-virus-quickly
Too many significant digits.
Benjy Renton (@bhrenton):
Dr. Chris Murray at @IHME_UW explains the reasons behind his model’s new predictions — 175,168 deaths by October 1.
- Seasonality — fall could get worse
- Back to school — not just students, but actions around schools including parents
- Complacency by the general public https://t.co/JZTbB8dLN8
The @nytimes has updated their coronavirus vaccine tracker, but it’s worth adding a mental asterix to that “1.” The Chinese company CanSino has received temporary approval to use their Ad5 vaccine in the military. What details do we have so far? 1/6
Now is probably the worst possible time to criticize public health experts, but if we are having this conversation, let’s be honest about it. The early messaging around masks was confusing and bad. 🤷🏻♀️
Yesterday I posted about how co-first author @CJEMetcalf was described in a recent @ScienceMagazine article. Thanks to editor @johnstravis for replying. Sharing his response.
John Travis (@johnstravis):
@nataliexdean @ScienceMagazine @CJEMetcalf Thanks for asking. We strive to reflect credit and no disrespect was intended. We led with Mina because he’s the antibody specialist & PI on the grant (~$1.8 mil) for the COVID-19 pilot project, which arose from GIO concept developed with @CJEMetcalf. 1/2
What is key to a successful vaccine efficacy trial? Picking the right trial sites! If we place the trial in outbreak hotspots, we can quickly determine if the vaccine is effective for preventing disease.
A thread on our proposed strategy. 1/11 https://www.mobs-lab.org/uploads/6/7/8/7/6787877/ensembleforecastvaccines_12jun20.pdf
Hi @ScienceMagazine. Thanks for sharing an innovative idea from a recently published paper, but why is tenured professor and co-first author Jessica Metcalf @CJEMetcalf not mentioned until paragraph 8? https://science.sciencemag.org/content/368/6498/1413.full https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292646/
Do male scientists get scolded for politely declining media requests? I talked to five separate reporters today. I need to get my work done.
THINK LIKE AN EPIDEMIOLOGIST:
What does it mean that the median age of new cases is dropping in some areas? I see three possible explanations, not all good. A thread on how to distinguish between them. 1/10
(Figure h/t @ScottGottliebMD)